3rd Edition

The Toxicologist's Pocket Handbook

By Michael J. Derelanko Copyright 2018
531 Pages 22 B/W Illustrations
by CRC Press

531 Pages 22 B/W Illustrations
by CRC Press

531 Pages 22 B/W Illustrations
by CRC Press

The third edition of the Toxicologist’s Pocket Handbook , like the first two editions, is a scaled-down version of the best-selling Handbook of Toxicology . It provides the most frequently used toxicology reference information in a convenient pocket-sized book. The format remains the same as the earlier editions to allow basic reference information to be located quickly, with the information... Read more

1. Lab Animals

2. General Toxicology

3. Inhalation Toxicology

4. Dermal Toxicology

5. Ocular Toxicology

6. Genetic Toxicology/Carcinogenesis

7. Neurotoxicology

8. Immunotoxicology

9. Reproductive/Developmental Toxicology

10. Clinical Pathology

11. Risk Assessment

12. Human Clinical Toxicology

13. Industrial Chemical Toxicology

14. Pharmaceutical and Related Toxicology

15. Miscellaneous Information

16. Glossary—by Subject

17. Glossary—Alphabetical

Biography

Michael J. Derelanko, Ph.D., D.A.B.T., F.A.T.S., has spent most of his career as a toxicologist in the pharmaceutical and chemical industries. Dr. Derelanko received a B.S. degree from Saint Peter’s University (formerly Saint Peter’s College). He was a National Institutes of Health predoctoral trainee in the Albert S. Gordon Laboratory of Experimental Hematology at New York University, achieving M.S. and Ph.D. degrees. He received the New York University Gladys Mateyko Award for Excellence in Biology. Following a two-year postdoctoral fellowship in gastrointestinal pharmacology at Schering-Plough Corporation, he began his career in industrial toxicology as a research toxicologist in the laboratories of Allied Chemical Corporation in Morristown New Jersey which eventually became AlliedSignal and later Honeywell International. Over a 20 year period, Dr. Derelanko held various positions of increasing responsibility becoming Corporate Manager of Toxicology and Risk Assessment. He most recently was Director of Nonclinical Drug Safety Assessment for Adolor Corporation in Exton, Pennsylvania where he contributed to the discovery and development of novel drugs for nearly 10 years.